טוען...
Bone-Targeted Therapy in Metastatic Breast Cancer – All Well-Established Knowledge?
Bone-targeted therapies like bisphosphonates (zoledronic acid or pamidronate) or denosumab are recommended in all patients with metastatic breast cancer and bone metastases, whether they are symptomatic or not. The choice between these 2 different agents, however, remains open. In this review, we cr...
שמור ב:
| הוצא לאור ב: | Breast Care (Basel) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
S. Karger GmbH
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4322685/ https://ncbi.nlm.nih.gov/pubmed/25759612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368710 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|